l 767679 has been researched along with verapamil in 1 studies
Studies (l 767679) | Trials (l 767679) | Recent Studies (post-2010) (l 767679) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
7 | 0 | 0 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohn, D; DeLuna, P; Gorham, LM; Leung, K; Lin, JH; Ma, B; Pang, J; Prueksaritanont, T; Xu, X | 1 |
1 other study(ies) available for l 767679 and verapamil
Article | Year |
---|---|
In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Alanine; Caco-2 Cells; Humans; Intestinal Mucosa; Male; Piperazines; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Quinidine; Rats; Rats, Sprague-Dawley; Verapamil | 1998 |